Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent

por You, Ming-Liang, Chen, Yi-Jun, Chong, Qing-Yun, Wu, Ming-Ming, Pandey, Vijay, Chen, Ru-Mei, Liu, Liang, Ma, Lan, Wu, Zheng-Sheng, Zhu, Tao, Lobie, Peter E
Publicado 2017

Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma

por Poh, Han Ming, Chiou, Yi Shiou, Chong, Qing Yun, Chen, Ru-Mei, Rangappa, Kanchugarakoppal S., Ma, Lan, Zhu, Tao, Kumar, Alan Prem, Pandey, Vijay, Basappa, Lee, Soo-Chin, Lobie, Peter E.
Publicado 2019

Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK

por Chen, Ru-Mei, Chiou, Yi-Shiou, Chong, Qing-Yun, Poh, Han-Ming, Tan, Tuan-Zea, Zhang, Meng-Yi, Ma, Lan, Zhu, Tao, Pandey, Vijay, Basappa, Kumar, Alan Prem, Lobie, Peter E.
Publicado 2019

A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma

por Zhang, Mengyi, Wang, Baocheng, Chong, Qing-Yun, Pandey, Vijay, Guo, Zhirong, Chen, Ru-Mei, Wang, Lingzhi, Wang, Yanxin, Ma, Lan, Kumar, Alan P., Zhu, Tao, Wu, Zheng-Sheng, Yin, Zhinan, Basappa, Goh, Boon-Cher, Lobie, Peter E.
Publicado 2019